Why anti-cancer drugs do not always live up to expectations
For more than a decade, a class of drugs called BET inhibitors has been tested in cancer trials with high expectations. The biology looked promising. Many cancers depend on oncogenes that "Bromo- and Extra-Terminal domain" ...
3 minutes ago
0
0









